Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial register facet

No retrievable report trial records

7 records with the status no retrievable report.

Showing 0 records on this page

Records

7 documents

Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.

RecordCompoundPhaseStatusDesignRandomisedYearCertainty
EPI-RU-ELDERLYEpithalonNo retrievable reportObservationalNot rated
BPC-PH2-UCBPC-157Phase 2No retrievable reportRandomised, double-blind, placebo-controlledNot rated
THYMALIN-RU-1ThymalinNo retrievable reportObservationalNot rated
SEMAX-RU-COGNITIVESemaxNo retrievable reportObservationalNot rated
SEMAX-RU-STROKESemaxNo retrievable reportObservationalNot rated
SELANK-RU-ANXIETYSelankNo retrievable reportObservationalNot rated
DSIP-HIST-SLEEPDSIPNo retrievable reportRandomised crossoverNot rated
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.